Molecular and cellular mechanisms of antidepressant drugs

Depression and Anxiety

Volumn 4, Issue 4, 1996, Pages 153-159

  Owens, Michael J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

antidepressants; mechanisms; neurotransmission; norepinephrine; serotonin

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; AUTORECEPTOR; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MAPROTILINE; MONOAMINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NISOXETINE; NORADRENALIN; NORTRIPTYLINE; PAROXETINE; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN RECEPTOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

AMINE TRANSPORT; ARTICLE; DEPRESSION; DRUG MECHANISM; DRUG RECEPTOR BINDING; ELECTROCONVULSIVE THERAPY; HUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; SEROTONINERGIC TRANSMISSION;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; DEPRESSIVE DISORDER; HUMANS; NEUROTRANSMITTER AGENTS; RECEPTORS, ADRENERGIC; RECEPTORS, NEUROTRANSMITTER; RECEPTORS, SEROTONIN; SYNAPTIC TRANSMISSION;

EID: 0030433327     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6394(1996)4:4<153::AID-DA1>3.0.CO;2-G     Document Type: Article

References (35)

1. Barker EL, Blakely RD (1995) Norepinephrine and serotonin transporters: molecular targets of antidepressant drugs. In Bloom FE, Kupfer DJ (eds): Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press, pp 321-334.
2. Barker EL, Kimmel HL, Blakely RD (1994) Chimeric human and rat serotonin transporters reveal domains involved in recognition of transporter ligands. Mol Pharmacol 46:799-807.
3. 3H]-nisoxetine autoradiography. Brain Res 582:208-214.
4. Bel N, Artigas F (1993) Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse 15:243-245.
5. Blier P, de Montigny C (1985) Serotoninergic but not noradrenergic neurons in rat central nervous system adapt to long-term treatment with monoamine oxidase inhibitors. Neuroscience 16:949-955.
6. Blier P, Chaput Y, de Montigny C (1988) Long-term 5-HT reuptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: An electrophysiological study in the rat brain. Naunyn-Schmiedebergs Arch Pharmacol 337:246-254.
7. Blier P, Mongeau R, Weiss M, de Montigny C (1993) Modulation of serotonin neurotransmission by presynaptic alpha-2-adrenergic receptors: A target for antidepressant pharmacotherapy? In Mendlewicz J, Brunello N, Langer SZ, Racagni G (eds): New Pharmacological Approaches to the Therapy of Depressive Disorders, Int. Acad. Biomed Drug Res. Vol. 5, Basel: Karger, pp 74-82.
8. Bolden-Watson C, Richelson E (1993) Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sci 52:1023-1029.
9. Burnet PW, Michelson D, Smith MA, Gold PW, Sternberg EM (1994) The effect of chronic imipramine administration on the densities of 5-HT1A and 5-HT2 receptors and the abundances of 5-HT receptor and transporter mRNA in the cortex, hippocampus, and dorsal raphe of three strains of rat. Brain Res 638:311-324.
10. Chaput Y, Blier P, de Montigny C (1986) In vivo electrophysiological evidence for the regulatory role of autoreceptors on serotonergic terminals. J Neurosci 6:2796-2801.
11. Chaput Y, de Montigny C, Blier P (1991) Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of anridepressant treatments. An in vivo electrophysiological study in the rat. Neuropsychopharmacology 5:219-229.
12. 3H]-Paroxetine binding and serotonin content of rat brain: Absence of changes following antidepressant treatments. Eur J Pharmacol 235:137-142.
13. Duman RS, Nestler EJ (1995) Signal transduction pathways for catecholamine receptors. In Bloom FE, Kupfer DJ (eds): Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press, pp 303-320.
14. 3H]-paroxetine binding to the 5-HT uptake site in rat cortical membranes. Psychopharmacology 95:68-70.
15. 3H]-paroxetine binding to cerebral cortex membranes of the rat. Neuropharmacology 26:1087-1092.
16. Hrdina PD, Vu TB (1993) Chronic fluoxetine treatment upregulates 5-HT uptake sites and 5-HT2 receptors in rat brain: An autoradiographic study. Synapse 14:324-331.
17. Hyman SE, Nestler EJ (1993) The Molecular Foundations of Psychiatry. Washington, DC: American Psychiatric Press.
18. Kovachich GB, Frazer A, Aronson CE (1993) Effect of chronic administration of antidepressants on α2-adrenoceptors in the locus coeruleus and its projection fields in rat brain determined by quantitative autoradiography. Neuropsychopharmacology 8:57-65.
19. Lesch KP, Aulakh CS, Wolozin BL, Tolliver TJ, Hill JL, Murphy DL (1993) Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants. Mol Brain Res 17:31-35.
20. Lopez JF, Chalmers DT, Vazquez DM, Watson SJ, Akil H (1994) Serotonin transporter mRNA in rat brain is regulated by classical antidepressants. Biol Psychiatry 35:287-290.
21. Mongeau R, de Montigny C, Blier P (1994) Electrophysiologic evidence for desensitization of α2-adrenoceptors on serotonin terminals following long-term treatment with drugs increasing norepinephrine synaptic concentration. Neuropsychopharmacology 10:41-51.
22. 125I]-cyanopindolol binding to 5-HT1B receptors in rat brain. Eur J Pharmacol 196:327-329.
23. Nestler EJ, Duman RS (1995) Intracellular messenger pathways as mediators of neural plasticity. In Bloom FE, Kupfer DJ (eds): Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press, pp 695-704.
24. Nestler EJ, McMahon A, Sabban EL, Tallman JF, Duman RS (1990) Chronic antidepressant administration decreases the expression of tyrosine hydroxylase in the rat locus ceoruleus. Proc Natl Acad Sci USA 87:7522-7526.
25. Owens MJ, Nemeroff CB (1994) Role of serotonin in the pathophysiology of depression: Focus on the serotonin transporter. Clin Chem 40:288-295.
26. Owens MJ, Morgan WN, Plott SE, Ieni J, Nemeroff CB (1995) In vitro inhibition of the rat and human serotonin and norepinephrine transporter by the antidepressant nefazodone and its metabolites. Soc Neurosci Abstr 21:766.
27. Pacholyczyk T, Blakely RD, Amara SG (1991) Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 350:350-354.
28. Paul IA, Nowak G, Layer RT, Popik P, Skolnick P (1994) Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments, J Pharmacol Exp Ther 269:95-102.
29. Piñeyro G, Blier P, Dennis T, de Montigny C (1994) Desensitization of the neuronal 5-HT carrier following its long-term blockade. J Neurosci 14:3036-3047.
30. Pryor JC, Sulser F (1990) Evolution of the monoamine hypotheses of depression. In Horton RW, Katona C (eds): Biological Aspects of Affective Disorders. London: Academic Press, pp 77-94.
31. Qian Y, Melikian HE, Rye DB, Levey AI, Blakely RD (1995) Identification and characterization of antidepressant-sensitive serotonin transporter proteins using site-specific antibodies. J Neurosci 15:1261-1274.
32. Ramamoorthy S, Bauman AL, Moore KR, Han H, Yang-Feng T, Chang AS, Ganapathy V, Blakely RD (1993a) Antidepressant-and cocaine-sensitive human serotonin transporter: Molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci USA 90:2542-2546.
33. Ramamoorthy S, Cool DR, Mahesh VB, Leibach FH, Melikian HE, Blakely RD, Ganapathy V (1993b) Regulation of the human serotonin transporter. Cholera toxin-induced stimulation of serotonin uptake in human placental choriocarcinoma cells is accompanied by increased serotonin transporter mRNA levels and serotonin transporter-specific ligand binding. J Biol Chem 208:21626-21631.
34. 7 receptor binding sites in rat hypothalmus: Sensitivity to chronic antidepressant treatment. Mol Pharmacol 47:99-103.
35. Vetulani J, Sulser F (1975) Actions of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain. Nature 257:495-496.